February 7, 2025 · Form 4 insider transaction
Graham Jonathan P sold 25,045 shares of Amgen Inc. at $293.12 per share, a transaction worth $7.34M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
The price reported is an average price. Full information regarding the number of shares sold at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.; These shares include 634 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.